HD

Hamir Devkrandas Kanani

Active Director Whole-Time Director DIN 00524184
DIN 00524184 First appointment Mar 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Hamir Devkrandas Kanani

Data last updated:

Hamir Devkrandas Kanani is a Whole-Time Director at Baijul Pharma Pvt Ltd (since 2025). The company operates in Chemicals. Baijul Pharma Pvt Ltd reported revenue of ₹2.35 Cr (FY 2025).

DIN 00524184
Primary Designation Whole-Time Director
Industry Chemicals
First Appointment 10 Mar 2025
Oldest Company Age 33 yrs
Largest company Baijul Pharma Pvt Ltd · ₹2.35 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Baijul Pharma Pvt Ltd U24231GJ1992PTC018670
Whole-Time Director10 Mar 20251992₹2.35 Cr (FY 2025)Active

Board colleagues of Hamir Devkrandas Kanani

NameDINCompanyDesignation
Chetna Hamir Kanani08906332Baijul Pharma Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Baijul Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Hamir Devkrandas Kanani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hamir Devkrandas Kanani

Hamir Devkrandas Kanani currently holds 1 directorship: Baijul Pharma Pvt Ltd (Whole-Time Director, since 10 Mar 2025, revenue ₹2.35 Cr (FY 2025)).

Hamir Devkrandas Kanani was first appointed on 10 Mar 2025 as Whole-Time Director at Baijul Pharma Pvt Ltd.

The current boards of Hamir Devkrandas Kanani's companies include Chetna Hamir Kanani (Baijul Pharma Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available